FDA Adverse Event Injury Summary report: N

SPRINT FIDELIS

MDR report key: 2953193 · Received February 9, 2013

Report

Report Number
2649622-2013-00970
Event Type
Injury
Date Received
February 9, 2013
Report Date
December 14, 2012
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT DEVICES. 5076 IMPLANTABLE PACING LEAD, (B)(6) 2007 BETA BLOCKER, ACE INHIBITOR, WARFARIN, DIURETIC, STATIN, ANTIBIOTIC. (B)(4). NO EVAL EXPLANATION: LEAD WAS NOT RETURNED TO THE MANUFACTURER.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD RECURRENT (B)(6). TRANSESOPHAGEAL ECHOCARDIOGRAPHY DONE SHOWED ECHODENSITY ON THE RIGHT VENTRICULAR LEAD AS IT TRANSVERSES THE RIGHT ATRIAL LEAD AND 2+ MR WITH A POST LEAFLET VALVE ECHODENSITY. THE SYSTEM WAS EXPLANTED AND REPLACED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
56980 SPRINT FIDELIS DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS MPRI 694965

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R (B)(4) IMPLANTABLE CARDIOVERTER DEFIBRILLATOR